The high-quality value of 10x Genomics Inc (TXG) Stock is hidden beneath the surface
Guggenheim raised the price target for the 10x Genomics Inc (NASDAQ:TXG) stock to “a Buy”. The rating was released on December 14, 2023, according to finviz. The research report from BofA Securities has upgraded the stock from Underperform to Neutral, with a price target set at $54. The stock was resumed by JP Morgan, who […]
Why 10x Genomics Inc (NASDAQ:TXG) Stock down -17.58% in Last Week?
Guggenheim raised the price target for the 10x Genomics Inc (NASDAQ:TXG) stock to “a Buy”. The rating was released on December 14, 2023, according to finviz. The research report from BofA Securities has upgraded the stock from Underperform to Neutral, with a price target set at $54. The stock was resumed by JP Morgan, who […]
Why 10x Genomics Inc (NASDAQ:TXG) Stock fell -15.71% in Last Six Months?
Guggenheim raised the price target for the 10x Genomics Inc (NASDAQ:TXG) stock to “a Buy”. The rating was released on December 14, 2023, according to finviz. The research report from BofA Securities has upgraded the stock from Underperform to Neutral, with a price target set at $54. The stock was resumed by JP Morgan, who […]
Will Earnings Beat Estimates? 10x Genomics Inc (TXG) Stock
Guggenheim raised the price target for the 10x Genomics Inc (NASDAQ:TXG) stock to “a Buy”. The rating was released on December 14, 2023, according to finviz. The research report from BofA Securities has upgraded the stock from Underperform to Neutral, with a price target set at $54. The stock was resumed by JP Morgan, who […]
There is no better tap than 10x Genomics Inc (TXG) Stock
Guggenheim raised the price target for the 10x Genomics Inc (NASDAQ:TXG) stock to “a Buy”. The rating was released on December 14, 2023, according to finviz. The research report from BofA Securities has upgraded the stock from Underperform to Neutral, with a price target set at $54. The stock was resumed by JP Morgan, who […]
Guggenheim Assigned “a Buy” Rating to 10x Genomics Inc (NASDAQ:TXG) Stock
Guggenheim raised the price target for the 10x Genomics Inc (NASDAQ:TXG) stock to “a Buy”. The rating was released on December 14, 2023, according to finviz. The research report from BofA Securities has upgraded the stock from Underperform to Neutral, with a price target set at $54. The stock was resumed by JP Morgan, who […]
What does 10x Genomics Inc (TXG) Stock have to offer?
Guggenheim raised the price target for the 10x Genomics Inc (NASDAQ:TXG) stock to “a Buy”. The rating was released on December 14, 2023, according to finviz. The research report from BofA Securities has upgraded the stock from Underperform to Neutral, with a price target set at $54. The stock was resumed by JP Morgan, who […]
10x Genomics Inc (TXG) Stock offers help to cash-strapped investors
Guggenheim raised the price target for the 10x Genomics Inc (NASDAQ:TXG) stock to “a Buy”. The rating was released on December 14, 2023, according to finviz. The research report from BofA Securities has upgraded the stock from Underperform to Neutral, with a price target set at $54. The stock was resumed by JP Morgan, who […]
